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In the paper by Tanokashira *et al*. \[1\], there was an error in Fig. [1](#feb412536-fig-0005){ref-type="fig"}, part 1a. The correct figure is reproduced below.

![Long‐term metformin treatment stimulates the phosphorylation of IRS1 at some serine residues. (A) Total and phosphorylated forms of hippocampal proteins isolated from middle‐aged WT (*n* = 4 animals; 35 weeks of age), middle‐aged DIO (*n* = 4 animals; 45 weeks of age), or metformin‐treated DIO mice (*n* = 4 animals; 45 weeks of age) were detected by specific antibodies. Levels of phosphorylation were normalized by levels of total protein expression. β‐Tubulin was used as a loading control. (B--I) Graphs present relative levels of phosphorylated insulin receptor β \[B\], IRS1 (mSer307, mSer612, mSer632/Ser635, or mSer1097) \[C--F\], AMPK \[G\], aPKC ζ/λ \[H\], and mTOR \[I\]. (J) Schematic representation of metformin‐stimulated phosphorylation of AMPK/IRS1/ aPKC ζ/λ. Data are the mean ± SEM. Significances were determined using Student\'s *t*‐test. \**P* \< 0.05; \*\**P* \< 0.01.](FEB4-8-1882-g001){#feb412536-fig-0005}
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